Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib.
Shumilov E, Wulf G, Ströbel P, Hasenkamp J, Hellige N, Bleckmann A, Haase D, Braulke F, Jung W, Schanz J, Binder M, Trümper L, Bacher U. Shumilov E, et al. Among authors: hasenkamp j. Leuk Lymphoma. 2016 Oct;57(10):2476-80. doi: 10.3109/10428194.2016.1151510. Epub 2016 Feb 25. Leuk Lymphoma. 2016. PMID: 26916814 No abstract available.
Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease.
Wulf G, Hasenkamp J, Jung W, Wilhelm C, Held G, Nickelsen M, Leha A, Pfreundschuh M, Schmitz N, Trümper L, Glass B. Wulf G, et al. Among authors: hasenkamp j. Bone Marrow Transplant. 2019 Jun;54(6):877-884. doi: 10.1038/s41409-018-0360-9. Epub 2018 Nov 9. Bone Marrow Transplant. 2019. PMID: 30413811
Outcomes of second allogeneic stem cell transplantation and anti-relapse strategies in patients with relapsed/refractory acute myeloid leukemia: A unicentric retrospective analysis.
Shumilov E, Hasenkamp J, Maulhardt M, Mazzeo P, Schmidt N, Boyadzhiev H, Jung W, Ganster C, Haase D, Koch R, Wulf G. Shumilov E, et al. Among authors: hasenkamp j. Hematol Oncol. 2022 Oct;40(4):763-776. doi: 10.1002/hon.2995. Epub 2022 Apr 18. Hematol Oncol. 2022. PMID: 35368106
Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial.
Glass B, Hasenkamp J, Wulf G, Dreger P, Pfreundschuh M, Gramatzki M, Silling G, Wilhelm C, Zeis M, Görlitz A, Pfeiffer S, Hilgers R, Truemper L, Schmitz N; German High-Grade Lymphoma Study Group. Glass B, et al. Among authors: hasenkamp j. Lancet Oncol. 2014 Jun;15(7):757-66. doi: 10.1016/S1470-2045(14)70161-5. Epub 2014 May 11. Lancet Oncol. 2014. PMID: 24827808 Clinical Trial.
Stem cell transplantation for hemoglobinopathy Vila Real.
Hasenkamp J, Riggert J, Jung W, Boyadzhiev H, Valk J, Trümper L, Wulf G. Hasenkamp J, et al. Ann Hematol. 2021 Dec;100(12):3041-3042. doi: 10.1007/s00277-020-04237-6. Epub 2020 Sep 3. Ann Hematol. 2021. PMID: 32885286 Free PMC article. No abstract available.
49 results